Upgrades/Downgrades
Updated: 09-Sep-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| UGI Corp | UGI | Jefferies | Hold » Buy | $43 | |
| Thermo Fisher | TMO | UBS | Neutral » Buy | $730 | |
| Summit Therapeutics | SMMT | Jefferies | Hold » Buy | $25 | |
| Sasol | SSL | BofA Securities | Neutral » Buy | ||
| Sagimet Biosciences | SGMT | Barclays | Equal Weight » Overweight | $18 | |
| Martin Marietta | MLM | Wells Fargo | Equal Weight » Overweight | $609 | |
| Lineage | LINE | Morgan Stanley | Equal-Weight » Overweight | $47 | |
| Figure Technology Solutions | FIGR | BofA Securities | Underperform » Neutral | $49 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Westlake Corporation | WLK | BMO Capital Markets | Outperform » Market Perform | $82 | |
| Vulcan Materials | VMC | Wells Fargo | Equal Weight » Underweight | $254 | |
| Patria Investments | PAX | BofA Securities | Neutral » Underperform | $10 | |
| Novartis AG | NVS | Deutsche Bank | Buy » Hold | ||
| LVMH | LVMUY | HSBC Securities | Buy » Hold | ||
| Eagle Materials | EXP | Wells Fargo | Overweight » Equal Weight | $196 | |
| Dyne Therapeutics | DYN | JP Morgan | Neutral » Underweight | $10 | |
| Amrize | AMRZ | Wells Fargo | Overweight » Equal Weight | $44 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| XPeng | XPEV | UBS | Neutral | ||
| X-Energy | XE | Piper Sandler | Underweight | $9 | |
| Victoria's Secret | VSXY | BMO Capital Markets | Market Perform | $80 | |
| Viatris | VTRS | Leerink Partners | Outperform | $20 | |
| Urban Outfitters | URBN | BMO Capital Markets | Market Perform | $80 | |
| Upstart | UPST | Loop Capital | Hold | $34 | |
| Ulta Beauty | ULTA | BMO Capital Markets | Market Perform | $580 | |
| TriSalus Life Sciences | TLSI | H.C. Wainwright | Buy | $11 | |
| Teva Pharma | TEVA | Leerink Partners | Outperform | $45 | |
| Steven Madden | SHOO | BMO Capital Markets | Outperform | $60 | |
| SoFi Technologies | SOFI | Loop Capital | Hold | $22 | |
| Sanofi | SNY | RBC Capital Mkts | Sector Perform | ||
| Sagimet Biosciences | SGMT | Cantor Fitzgerald | Overweight | ||
| Roche Hldg | RHHBY | RBC Capital Mkts | Outperform | ||
| Quanta Services | PWR | Piper Sandler | Overweight | $731 | |
| Pursuit Attractions and Hospitality | PRSU | Jefferies | Buy | $61 | |
| Primoris Services | PRIM | Piper Sandler | Neutral | $90 | |
| Phathom Pharmaceuticals | PHAT | Leerink Partners | Market Perform | $10 | |
| Pacira BioSciences | PCRX | Leerink Partners | Market Perform | $28 | |
| On | ONON | BMO Capital Markets | Market Perform | $28 | |
| Oklo Inc. | OKLO | Piper Sandler | Overweight | $55 | |
| Obsidian Therapeutics | OBX | William Blair | Outperform | ||
| Novartis AG | NVS | RBC Capital Mkts | Sector Perform | ||
| NIKE | NKE | BMO Capital Markets | Underperform | $30 | |
| Nextpower | NXT | Piper Sandler | Overweight | $116 | |
| Nautilus Biotechnology | NAUT | Leerink Partners | Outperform | $4 | |
| Mobility Global | MBGL | Evercore ISI | In-line | $22 | |
| MasTec | MTZ | Piper Sandler | Overweight | $321 | |
| lululemon athletica | LULU | BMO Capital Markets | Underperform | $70 | |
| Lindblad Expeditions | LIND | Jefferies | Hold | $29 | |
| Formula One Group C | FWONK | Jefferies | Buy | $115 | |
| Kodiak AI | KDK | Needham | Buy | $8 | |
| Klarna Group plc | KLAR | Loop Capital | Hold | $18 | |
| Harrow | HROW | Leerink Partners | Outperform | $45 | |
| GSK plc | GSK | RBC Capital Mkts | Sector Perform | ||
| Gap | GAP | BMO Capital Markets | Market Perform | $23 | |
| Fluence | FLNC | Piper Sandler | Underweight | $6 | |
| First Solar | FSLR | Piper Sandler | Overweight | $260 | |
| Faeth Therapeutics | FTH | TD Cowen | Buy | ||
| Twist Bioscience | TWST | BWS Financial | Sell | $45 | |
| Dick's Sporting Goods | DKS | BMO Capital Markets | Underperform | $110 | |
| Deckers Outdoor | DECK | BMO Capital Markets | Underperform | $70 | |
| Dave, Inc. | DAVE | Loop Capital | Buy | $500 | |
| The Cigna Group | CI | Evercore ISI | In-line | $290 | |
| Chime | CHYM | Loop Capital | Buy | $45 | |
| Carter's | CRI | BMO Capital Markets | Outperform | $40 | |
| Caris Life Sciences | CAI | UBS | Neutral | $28 | |
| Birkenstock Holding Plc | BIRK | BMO Capital Markets | Market Perform | $35 | |
| Bausch + Lomb | BLCO | Leerink Partners | Outperform | $24 | |
| Bath & Body Works | BBWI | BMO Capital Markets | Market Perform | $20 | |
| AstraZeneca | AZN | RBC Capital Mkts | Outperform | ||
| Array Tech | ARRY | Piper Sandler | Neutral | $5 | |
| Argan | AGX | Piper Sandler | Underweight | $273 | |
| Amer Sports | AS | BMO Capital Markets | Outperform | $38 | |
| American Eagle | AEO | BMO Capital Markets | Market Perform | $18 | |
| Amneal Pharmaceuticals | AMRX | Leerink Partners | Outperform | $23 | |
| Aktis Oncology | AKTS | Oppenheimer | Outperform | $40 | |
| Affirm | AFRM | Loop Capital | Buy | $105 | |
| AEON Biopharma | AEON | Laidlaw | Buy | $1.80 | |
| Academy Sports + Outdoors | ASO | BMO Capital Markets | Market Perform | $42 | |
| Abercrombie & Fitch | ANF | BMO Capital Markets | Outperform | $170 | |
| Uber | UBER | Scotiabank | Sector Outperform | $100 | |
| DoorDash | DASH | Scotiabank | Sector Outperform | $275 | |
| Lyft | LYFT | Scotiabank | Sector Perform | $17 | |
| Twist Bioscience | TWST | UBS | Neutral | $144 | |
| Tempus AI | TEM | UBS | Neutral | $70 | |
| Stevanato Group S.p.A. | STVN | UBS | Neutral | ||
| FuelCell Energy | FCEL | Craig Hallum | Buy | $22 | |
| Collegium Pharmaceutical | COLL | Leerink Partners | Outperform | $45 | |
| Bruker | BRKR | UBS | Neutral | $65 | |
| Better Home & Finance | BETR | B. Riley Securities | Buy | $26 | |
| Avantor | AVTR | UBS | Neutral | $16 | |
| ANI Pharma | ANIP | Leerink Partners | Outperform | $104 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Lithium Americas | LAC | JP Morgan | Overweight | $6 | |
| Illumina | ILMN | UBS | Buy | $260 | |
| Heartflow | HTFL | UBS | Neutral | $55 | |
| GRAIL | GRAL | UBS | Buy | $105 | |
| Danaher | DHR | UBS | Buy | $250 | |
| Collegium Pharmaceutical | COLL | Truist | Buy | $49 | |
| Franklin Templeton | BEN | Keefe Bruyette | Mkt Perform | $38 | |
| Invesco | IVZ | Keefe Bruyette | Outperform | $39 | |
| West Pharm | WST | UBS | Buy | $415 | |
| Waters | WAT | UBS | Buy | $490 | |
| 10x Genomics | TXG | UBS | Neutral | $68 | |
| Revvity | RVTY | UBS | Neutral | $140 | |
| Repligen | RGEN | UBS | Buy | $225 | |
| Qiagen | QGEN | UBS | Neutral | $47 | |
| Pacific Biosciences | PACB | UBS | Neutral | $1.35 | |
| Natera | NTRA | UBS | Buy | $435 | |
| Myriad Genetics | MYGN | UBS | Neutral | $3.60 | |
| Mettler-Toledo | MTD | UBS | Neutral | $1460 | |
| Guardant Health | GH | UBS | Buy | $225 | |
| Azul S.A. | AZUL | Deutsche Bank | Buy | $11 | |
| Agilent | A | UBS | Neutral | $165 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| ServiceTitan | TTAN | BMO Capital Markets | Outperform | $103 » $90 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |